Delving into the Latest Updates on Respiratory syncytial virus vaccine (Yidao Biotechnology) with Synapse

Overview

Basic Info

Drug Type

Prophylactic vaccine

Synonyms-

Target-

Action

stimulants

Mechanism

Immunostimulants

Therapeutic Areas

Infectious DiseasesRespiratory Diseases

Active Indication

Lower Respiratory Tract InfectionsRespiratory Syncytial Virus Infections

Inactive Indication-

Originator Organization

Yidao Biotechnology (Suzhou) Co., Ltd.

Active Organization

Yidao Biotechnology (Suzhou) Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1/2

First Approval Date-

Regulation-

Login to view timeline

Ⅰ期试验目的主要目的：评价不同剂量重组呼吸道合胞病毒疫苗（CHO细胞）在18岁及以上人群接种的安全性和耐受性。次要目的：初步探索不同剂量重组呼吸道合胞病毒疫苗（CHO细胞）在18岁及以上人群接种的免疫原性。 Ⅱ期试验目的主要目的：评价不同剂量重组呼吸道合胞病毒疫苗（CHO细胞）在60岁及以上人群接种的免疫原性。次要目的：评价不同剂量重组呼吸道合胞病毒疫苗（CHO细胞）在60岁及以上人群接种的安全性。

[Translation]

Phase I Trial Objectives: Primary Objective: To evaluate the safety and tolerability of different doses of the recombinant respiratory syncytial virus (RSV) vaccine (CHO cells) in individuals aged 18 years and older. Secondary Objective: To preliminarily explore the immunogenicity of different doses of the recombinant RSV vaccine (CHO cells) in individuals aged 18 years and older. Phase II Trial Objectives: Primary Objective: To evaluate the immunogenicity of different doses of the recombinant respiratory syncytial virus (RSV) vaccine (CHO cells) in individuals aged 60 years and older. Secondary Objective: To evaluate the safety of different doses of the recombinant respiratory syncytial virus (RSV) vaccine (CHO cells) in individuals aged 60 years and older.

Start Date-

Sponsor / Collaborator

Yidao Biotechnology (Suzhou) Co., Ltd.

100 Clinical Results associated with Respiratory syncytial virus vaccine (Yidao Biotechnology)

Login to view more data

100 Translational Medicine associated with Respiratory syncytial virus vaccine (Yidao Biotechnology)

Login to view more data

100 Patents (Medical) associated with Respiratory syncytial virus vaccine (Yidao Biotechnology)

Login to view more data

100 Deals associated with Respiratory syncytial virus vaccine (Yidao Biotechnology)

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Lower Respiratory Tract Infections	Phase 2	China	Yidao Biotechnology (Suzhou) Co., Ltd.	05 Dec 2025
Respiratory Syncytial Virus Infections	Phase 2	China	Yidao Biotechnology (Suzhou) Co., Ltd.	05 Dec 2025